Ronald E. Law

9.6k total citations · 2 hit papers
89 papers, 8.2k citations indexed

About

Ronald E. Law is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ronald E. Law has authored 89 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 26 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Ronald E. Law's work include Peroxisome Proliferator-Activated Receptors (34 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer, Lipids, and Metabolism (10 papers). Ronald E. Law is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (34 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer, Lipids, and Metabolism (10 papers). Ronald E. Law collaborates with scholars based in United States, Germany and Japan. Ronald E. Law's co-authors include Willa A. Hsueh, Ulrich Kintscher, Eckart Fleck, Kristof Graf, Xiao-Ping Xi, Stephan Goetze, Dennis Bruemmer, Christopher J. Lyon, Simon Jackson and Alan R. Collins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ronald E. Law

89 papers receiving 8.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

2002 778 citations Alan R. Collins, Grace Noh et al. profile →
Minireview: Adiposity, Inflammation, and Atherogenesis

2003 586 citations Ronald E. Law, Willa A. Hsueh et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ronald E. Law	4.6k	1.8k	1.4k	1.3k	1.2k	89	8.2k
Frank C. Brosius	4.1k 0.9×	1.5k 0.8×	1.6k 1.2×	1.6k 1.2×	680 0.5×	146	9.6k
Youfei Guan	4.4k 0.9×	1.6k 0.9×	859 0.6×	1.7k 1.3×	1.7k 1.4×	226	10.3k
Fuad N. Ziyadeh	6.3k 1.4×	1.6k 0.9×	2.1k 1.6×	1.5k 1.1×	899 0.7×	161	15.7k
Takanari Gotoda	3.8k 0.8×	3.1k 1.8×	1.2k 0.9×	1.3k 1.0×	1.4k 1.1×	114	8.4k
Colin H. Macphee	2.6k 0.6×	2.5k 1.4×	851 0.6×	970 0.7×	1.7k 1.4×	90	7.1k
Yi Zhu	3.4k 0.7×	1.2k 0.7×	885 0.7×	898 0.7×	964 0.8×	154	7.6k
Jifeng Zhang	5.3k 1.2×	1.5k 0.8×	1.4k 1.0×	1.7k 1.2×	1.1k 0.9×	227	9.5k
Hanna E. Abboud	3.7k 0.8×	1.1k 0.6×	885 0.7×	1.5k 1.1×	662 0.5×	166	9.0k
Bodo Levkau	4.8k 1.0×	2.0k 1.1×	1.8k 1.3×	838 0.6×	553 0.4×	157	9.2k
Jan Nilsson	2.3k 0.5×	1.7k 1.0×	1.3k 0.9×	899 0.7×	1.1k 0.9×	102	7.6k

Countries citing papers authored by Ronald E. Law

Since Specialization

Citations

This map shows the geographic impact of Ronald E. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Law more than expected).

Fields of papers citing papers by Ronald E. Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Law. The network helps show where Ronald E. Law may publish in the future.

Co-authorship network of co-authors of Ronald E. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Law. A scholar is included among the top collaborators of Ronald E. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Law. Ronald E. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schuhmacher, Alexander, et al.. (2013). How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective. Human Genomics. 7(1). 5–5. 12 indexed citations

Blaschke, Florian, Robert G. Spanheimer, Mehmood Khan, & Ronald E. Law. (2006). Vascular effects of TZDs: New implications. Vascular Pharmacology. 45(1). 3–18. 48 indexed citations

Collins, Alan R., Janet Schnee, Wei Wang, et al.. (2004). Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heart. Journal of the American College of Cardiology. 43(9). 1698–1705. 120 indexed citations

Blaschke, Florian, Dennis Bruemmer, & Ronald E. Law. (2004). Egr-1 is a Major Vascular Pathogenic Transcription Factor in Atherosclerosis and Restenosis. Reviews in Endocrine and Metabolic Disorders. 5(3). 249–254. 61 indexed citations

Bruemmer, Dennis, Rodney J. Dilley, Melanie E. Ivey, et al.. (2003). Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-γ Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation. Circulation. 107(20). 2548–2550. 79 indexed citations

Bruemmer, Dennis, Alan R. Collins, Grace Noh, et al.. (2003). Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. Journal of Clinical Investigation. 112(9). 1318–1331. 246 indexed citations

Bruemmer, Dennis & Ronald E. Law. (2003). Thiazolidinedione regulation of smooth muscle cell proliferation. The American Journal of Medicine. 115(8). 87–92. 28 indexed citations

Hsueh, Willa A. & Ronald E. Law. (2003). The central role of fat and effect of peroxisome proliferator-activated receptor–γ on progression of insulin resistance and cardiovascular disease. The American Journal of Cardiology. 92(4). 3–9. 97 indexed citations

Eibl, Guido, Dennis Bruemmer, Yuji Okada, et al.. (2003). PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. Biochemical and Biophysical Research Communications. 306(4). 887–897. 103 indexed citations

10.

Kintscher, Ulrich, Shu Wakino, Dennis Bruemmer, et al.. (2002). TGF-β1 induces peroxisome proliferator-activated receptor γ1 and γ2 expression in human THP-1 monocytes. Biochemical and Biophysical Research Communications. 297(4). 794–799. 21 indexed citations

11.

Goetze, Stephan, Ulrich Kintscher, Philipp Stawowy, et al.. (2002). PPAR activators inhibit endothelial cell migration by targeting Akt. Biochemical and Biophysical Research Communications. 293(5). 1431–1437. 130 indexed citations

12.

Wakino, Shu, Ronald E. Law, & Willa A. Hsueh. (2002). Vascular protective effects by activation of nuclear receptor PPARγ. Journal of Diabetes and its Complications. 16(1). 46–49. 35 indexed citations

13.

Wakino, Shu, Ulrich Kintscher, Zhaowei Liu, et al.. (2001). Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Mitogenic Induction of p21Cip1 by Modulating the Protein Kinase Cδ Pathway in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 276(50). 47650–47657. 67 indexed citations

14.

Wakino, Shu, Ulrich Kintscher, Sarah Kim-Hellmuth, et al.. (2000). Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 275(29). 22435–22441. 189 indexed citations

15.

Goetze, Stephan, Xiao-Ping Xi, Kristof Graf, et al.. (1999). Troglitazone inhibits angiotensin II‐induced extracellular signal‐regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells. FEBS Letters. 452(3). 277–282. 56 indexed citations

16.

Hsueh, Willa A. & Ronald E. Law. (1998). Cardiovascular risk continuum: implications of insulin resistance and diabetes. The American Journal of Medicine. 105(1). 4S–14S. 115 indexed citations

17.

Xi, Xiao-Ping, Kristof Graf, Stephan Goetze, Willa A. Hsueh, & Ronald E. Law. (1997). Inhibition of MAP kinase blocks insulin‐mediated DNA synthesis and transcriptional activation of c‐fos by Elk‐1 in vascular smooth muscle cells. FEBS Letters. 417(3). 283–286. 53 indexed citations

18.

Smith, D. Lynne, Ronald E. Law, Kathy Shaw, et al.. (1994). Proximal 2.6 kb of 5′-flanking DNA is insufficient for human renin promoter activity in renin-synthesizing chorio-decidual cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1219(2). 465–474. 13 indexed citations

19.

Law, Ronald E., Julie B. Stimmel, Michael A. Damore, et al.. (1992). Lipopolysaccharide-Induced NF-κB Activation in Mouse 70Z/3 Pre-B Lymphocytes Is Inhibited by Mevinolin and 5′-Methylthioadenosine: Roles of Protein Isoprenylation and Carboxyl Methylation Reactions. Molecular and Cellular Biology. 12(1). 103–111. 10 indexed citations

20.

Law, Ronald E., Adolph J. Ferro, Michael R. Cummings, & Stanley K. Shapiro. (1976). tRNA methyltransferases during embryogenesis in Musca domestica. Developmental Biology. 54(2). 304–307. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact